Patent · US Active

Polymorphic forms of metopimazine

US11834445B2 · kind B2 · utility

0Cited by
41References
24Claims
0Family size

Assignee

Inventor

  • Shu Yu · Xiangcheng District, CN

Key dates

Filing dateJun 9, 2022
Grant dateDec 5, 2023
Priority date—
Expiry dateJun 9, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are novel polymorphic forms of metopimazine mesylate. These polymorphic forms are useful in methods, compositions, and kits for the treatment of an enteric nervous system disorder.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.